Sohm, a generic pharmaceutical manufacturer, said that its new nutraceutical manufacturing facility in Ahmedabad, India has begun the commercial production of neutraceutical product line, including Diorac, a unique probiotic anti-diarrheal product.
Subscribe to our email newsletter
The in house manufacturing plant helps to extend Sohm’s core competence to include neutraceutical at a right time when the United States Food & Drug Administration and the Indian Food & Drug Administration are simplifying regulations in regard to neutraceutical deliverables.
Sohm president and CEO Shailesh Shah said the new plant is in compliance with all Dietary Supplement Health and Education Guidelines.
The company has also received an endorsement and necessary regulatory compliances with local authority as well as with the Indian Food & Drug Administration and Food Standards Authority of India.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.